标题
How long should we treat?
作者
关键词
Atypical fractures, Benefit-risk ratio, Bisphosphonates, Fractures, Long-term treatments, Osteoporosis, Osteonecrosis of the jaw, Stopping treatment
出版物
OSTEOPOROSIS INTERNATIONAL
Volume 25, Issue 6, Pages 1659-1666
出版商
Springer Nature
发表日期
2014-03-25
DOI
10.1007/s00198-013-2433-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw
- (2014) Parish P. Sedghizadeh et al. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION
- Compound risk of high mortality following osteoporotic fracture and refracture in elderly women and men
- (2013) Dana Bliuc et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Prevention of falls in the elderly—a review
- (2013) M. K. Karlsson et al. OSTEOPOROSIS INTERNATIONAL
- Meta-analysis: oral bisphosphonates and the risk of oesophageal cancer
- (2012) J. Andrici et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Risk of Fractures Following Cataract Surgery in Medicare Beneficiaries
- (2012) Victoria L. Tseng et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Real frequency of ordinary and atypical sub-trochanteric and diaphyseal fractures in France based on X-rays and medical file analysis
- (2012) Constance Beaudouin-Bazire et al. JOINT BONE SPINE
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2012) Dennis M Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT)
- (2012) Richard M Jacques et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study
- (2012) Bente Langdahl et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Incidence of atypical nontraumatic diaphyseal fractures of the femur
- (2012) Richard M Dell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Atypical Femur Fractures: 81 Individual Personal Histories
- (2012) Jennifer P. Schneider et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bisphosphonates for Osteoporosis — Where Do We Go from Here?
- (2012) Marcea Whitaker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Continuing Bisphosphonate Treatment for Osteoporosis — For Whom and for How Long?
- (2012) Dennis M. Black et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases
- (2012) M. Pazianas et al. OSTEOPOROSIS INTERNATIONAL
- Long-term mortality following fractures at different skeletal sites: a population-based cohort study
- (2012) L. J. Melton et al. OSTEOPOROSIS INTERNATIONAL
- Burden of pelvis fracture: a population-based study of incidence, hospitalisation and mortality
- (2012) D. Prieto-Alhambra et al. OSTEOPOROSIS INTERNATIONAL
- Bisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies
- (2012) K. Sun et al. OSTEOPOROSIS INTERNATIONAL
- Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate—Danish National Register Based Cohort Study
- (2012) M. Pazianas et al. OSTEOPOROSIS INTERNATIONAL
- Hip Fracture and Increased Short-term but Not Long-term Mortality in Healthy Older Women
- (2011) Erin S. LeBlanc ARCHIVES OF INTERNAL MEDICINE
- Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures
- (2011) Matthew Austin et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Previous fractures at multiple sites increase the risk for subsequent fractures: The global longitudinal study of osteoporosis in women
- (2011) Stephen Gehlbach et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension
- (2011) Socrates Papapoulos et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Esophageal and gastric cancer incidence and mortality in alendronate users
- (2011) Bo Abrahamsen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
- (2011) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bisphosphonate Use and Atypical Fractures of the Femoral Shaft
- (2011) Jörg Schilcher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis
- (2011) J-Y. Reginster et al. OSTEOPOROSIS INTERNATIONAL
- Exposure to Oral Bisphosphonates and Risk of Esophageal Cancer
- (2010) Chris R. Cardwell et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: The FLEX Trial
- (2010) Ann V Schwartz et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research
- (2010) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Biodemography of human ageing
- (2010) James W. Vaupel NATURE
- Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW)
- (2010) E. S. Siris et al. OSTEOPOROSIS INTERNATIONAL
- Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women
- (2009) Dana Bliuc JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Proximal Humeral Fracture as a Risk Factor for Subsequent Hip Fractures
- (2009) Jeremiah Clinton et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Prevalence of Osteonecrosis of the Jaw in Patients With Oral Bisphosphonate Exposure
- (2009) Joan C. Lo et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis
- (2008) C Roux et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical subsequent fractures cluster in time after first fractures
- (2008) T A C M van Geel et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial
- (2008) Jean-Yves Reginster et al. ARTHRITIS AND RHEUMATISM
- Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin
- (2008) Gerardo Heiss JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- To stop or not to stop, that is the question
- (2008) Ego Seeman OSTEOPOROSIS INTERNATIONAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started